Category: Prevention

Care after premenopausal risk-reducing salpingo-oophorectomy in high-risk women: Scoping review and international consensus recommendations

CONCLUSIONS

Despite the efficacy of premenopausal RRSO for reducing ovarian cancer risk and improving mortality in high-risk women, many women experience troublesome menopausal symptoms and oophorectomy may have adverse implications for long-term health.

Our panel of international experts has developed evidence-based recommendations for managing vasomotor, sleep, mood, sexual, and genitourinary symptoms and optimising bone and cardiovascular long-term health. Emerging evidence suggests that HRT reduces but does not eliminate the adverse effects of premenopausal oophorectomy. Women and clinicians considering RRSO should be aware of these risks and clinical care should focus on available safe options for symptom management and optimisation of long-term health.

https://obgyn.onlinelibrary.wiley.com/doi/full/10.1111/1471-0528.17511

GE Notes – Lynch Syndrome

Genomic Notes for Clinicians

Page contents:

https://www.genomicseducation.hee.nhs.uk/genotes/knowledge-hub/lynch-syndrome/

Is There a Lynch Syndrome Vaccine on the Way?

Lynch Syndrome, a genetic condition affecting around 1 million Americans annually, increases a person’s risk of developing colorectal cancer (CRC) to 20% – 80%.

As a result, Lynch Syndrome patients must complete yearly preventive screenings. However, developing a Lynch Syndrome vaccine could change the narrative for patients, reducing screenings and – more importantly – lowering risks for Lynch Syndrome-related cancers. 

“The advances in vaccine technologies, such as Lynch Syndrome, is a promising field of research that has the potential to reduce the risk of developing cancer, thereby preventing disease and modifying surveillance regimens for high-risk patients,” said David Fenstermacher, Senior Director of Research & Medical Affairs at the Colorectal Cancer Alliance.

https://www.ccalliance.org/blog/research/is-there-lynch-syndrome-vaccine

Carpe Diem A Little Harder After a Skin Cancer Scare

“…this lesion was positive for “the ugly duckling” sign as it was significantly darker than my other moles”

https://www2.curetoday.com/view/carpe-diem-a-little-harder-after-a-skin-cancer-scare

Lynch Syndrome

Key Points

  •  Lynch syndrome is a rare, inherited condition that increases your risk of developing bowel cancer and sometimes other cancers. 
  • Lynch Syndrome accounts for about 3% of all bowel cancer.  
  • Regular bowel screening by colonoscopy can prevent bowel cancers developing.  
  • Bowel Screening usually starts from the age of 25 years and is performed on a yearly basis.  
  • People with Lynch Syndrome are also at increased risk of developing certain other cancers such as uterine (womb), urinary tract, ovary and small bowel.  
  • Women should consider screening of the uterus and ovaries from the age of 30-35 years.  
  • Genetic testing is available for families with this syndrome.  
  • When you have Lynch Syndrome, each of your children have a 1 in 2 (50%) chance of inheriting it.  

https://www.nzfgcs.co.nz/Syndromes/Lynch-Syndrome

FREE cookbook

Spring has officially sprung but that doesn’t mean we can’t sit down and enjoy some tasty and healthy tomato soup! Head over to our website for the full FREE cookbook, designed and written by registered dietitians!

👉
Healthy Eating for Cancer Survivors

Acquired vs. Inherited Mutations in Cancer: What You Need to Know 

An example of an inherited risk of cancer is Lynch syndrome. A person with Lynch syndrome has an elevated risk of colorectal, endometrial, stomach, ovarian, urinary tract, other intestinal cancers, and additional cancers.

The increased risk is due to a mutation in one of several genes that fix mistakes made when DNA is copied. These genes are called DNA mismatch repair genes. The body has many mechanisms that work hard to prevent DNA copying errors and protect against cancer.

When one of those mechanisms is disabled by mutations, cancer is more likely to occur and at a younger age.

Acquired vs. Inherited Mutations in Cancer: What You Need to Know 

Vaccines to treat cancer possible by 2030, say BioNTech founders

mRNA Covid vaccine technology could be repurposed so that it primed the immune system to attack cancer cells.

BioNTech was working on mRNA cancer vaccines before the pandemic struck but the firm pivoted to produce Covid vaccines in the face of the global emergency. The firm now has several cancer vaccines in clinical trials. Türeci said the development and success of the Pfizer/BioNTech vaccine, which is similar to the Moderna Covid shot, “gives back to our cancer work”.

But Türeci(who co-founded BioNTech, the German firm that partnered with Pfizer to manufacture a revolutionary mRNA Covid vaccine) remained cautious about the work. “As scientists we are always hesitant to say we will have a cure for cancer,” she said. “We have a number of breakthroughs and we will continue to work on them.”

https://amp-theguardian-com.cdn.ampproject.org/v/s/amp.theguardian.com/society/2022/oct/16/vaccines-to-treat-cancer-possible-by-2030-say-biontech-founders?amp_gsa=1&amp_js_v=a9&usqp=mq331AQIKAGwASCAAgM%3D&fbclid=IwAR18d3jSHWXuKBI8FXgJLJWBjUvXvgnxI7zzvx6zkC-xCmPaa8Fk1LOE_QA#amp_tf=From%20%251%24s&aoh=16659558517121&csi=0&referrer=https%3A%2F%2Fwww.google.com&ampshare=https%3A%2F%2Fwww.theguardian.com%2Fsociety%2F2022%2Foct%2F16%2Fvaccines-to-treat-cancer-possible-by-2030-say-biontech-founders

Bowel Cancer Awareness Month

Very powerful sharing from Roberta. I think Genetic Counsellors everywhere will feel humbled that your experience was empowering & led to the correct diagnosis.

Highlights how important their role is, how families should know their cancer history & have the correct screening.